C4d/C4b Standard for Quantitative Flow Cytometry of Humoral Transplant Rejection

The invention concerns an internal standard used to quantitative analysis of the risk of humoral (i.e. vascular) transplant rejection. The internal standard consists of a stable composition of the C4d complement bound to a carrier consisting of erythrocytes or microparticles. The invention also concerns a method for analyzing in vitro the risk of humoral organ transplant rejection, which consists in determining the amount of component of C4d component fixed on the erythrocytes contained in a blood sample from a patient.

Patents:
US 20,090,305,311   [MORE INFO]

Inventor(s): COHEN JACQUES HENRI MAX [FR]; REVEIL BRIGITTE [FR]; KISSERLI AYMRIC [FR]; HAIDAR FADI [FR]; DONVITO BEATRICE [FR]

Type of Offer: Sale



« More Biotech Patents

---